Compare BMRA & VCIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BMRA | VCIG |
|---|---|---|
| Founded | 1971 | 2013 |
| Country | United States | Malaysia |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2M | 7.3M |
| IPO Year | N/A | 2023 |
| Metric | BMRA | VCIG |
|---|---|---|
| Price | $2.49 | $1.06 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 15.5K | ★ 7.1M |
| Earning Date | 01-13-2026 | 01-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.98 |
| Revenue | $4,884,000.00 | ★ $32,903,041.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.13 |
| Revenue Growth | N/A | ★ 24.77 |
| 52 Week Low | $2.08 | $0.89 |
| 52 Week High | $10.16 | $1,353.00 |
| Indicator | BMRA | VCIG |
|---|---|---|
| Relative Strength Index (RSI) | 52.29 | 38.51 |
| Support Level | $2.26 | $0.89 |
| Resistance Level | $2.39 | $1.28 |
| Average True Range (ATR) | 0.13 | 0.14 |
| MACD | 0.03 | 0.10 |
| Stochastic Oscillator | 76.53 | 43.59 |
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology development, solutions and consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment, which focuses on listing solutions, investor relations, and boardroom strategies consultancy.